Published in Front Mol Neurosci on December 15, 2016
Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade. Front Aging Neurosci (2017) 0.75
Multifarious Functions of the Fragile X Mental Retardation Protein. Trends Genet (2017) 0.75
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci (2000) 9.85
APP processing and synaptic function. Neuron (2003) 8.37
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron (2007) 6.60
Correction of fragile X syndrome in mice. Neuron (2007) 6.51
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron (2012) 4.31
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci U S A (2012) 2.84
FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol (2007) 2.75
Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet (2003) 2.66
Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol (2008) 2.46
Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci (2010) 2.42
Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron (2010) 2.34
Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci (2005) 2.34
Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci (2009) 2.33
Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience (2001) 2.31
Understanding the molecular basis of fragile X syndrome. Hum Mol Genet (2000) 2.13
FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci (2007) 2.02
Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron (2013) 2.00
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87
Epilepsy in fragile X syndrome. Dev Med Child Neurol (2002) 1.66
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem (2011) 1.63
Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Biol Psychiatry (2013) 1.50
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci (2012) 1.49
Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One (2010) 1.49
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav (2012) 1.41
Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J Neurosci (2011) 1.32
Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J Neurophysiol (1997) 1.26
Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett (2004) 1.26
Circuit level defects in the developing neocortex of Fragile X mice. Nat Neurosci (2013) 1.23
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res (2005) 1.20
Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ (1998) 1.19
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol (2006) 1.18
Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci (2010) 1.18
BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease. Neurobiol Aging (2007) 1.17
Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. PLoS One (2011) 1.15
BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci (2009) 1.14
The developmental switch in GABA polarity is delayed in fragile X mice. J Neurosci (2014) 1.14
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem (2011) 1.12
Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci (2014) 1.11
Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr (2013) 1.10
Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet (1997) 1.10
Extracellular signal-regulated kinase 1/2 is required for the induction of group I metabotropic glutamate receptor-mediated epileptiform discharges. J Neurosci (2004) 1.06
Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways. PLoS One (2009) 1.05
Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol (2002) 1.05
The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome. Dev Neurosci (2011) 1.05
Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway. PLoS One (2011) 1.03
Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. Int J Clin Exp Pathol (2008) 1.00
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat Commun (2014) 0.98
Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci (2013) 0.97
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Res (2011) 0.95
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome. Cell Cycle (2015) 0.94
What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders. Mol Psychiatry (2012) 0.93
Dual regulation of fragile X mental retardation protein by group I metabotropic glutamate receptors controls translation-dependent epileptogenesis in the hippocampus. J Neurosci (2011) 0.91
Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis (2010) 0.90
Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide. Brain Res (2009) 0.90
Differential metabotropic glutamate receptor expression and modulation in two neocortical inhibitory networks. J Neurophysiol (2009) 0.87
Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor. Neurochem Int (2009) 0.84
Plasticity mechanisms underlying mGluR-induced epileptogenesis. Adv Exp Med Biol (2004) 0.84
Soy-based diet exacerbates seizures in mouse models of neurological disease. J Alzheimers Dis (2013) 0.83
Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. Neuron (2015) 0.82
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. J Psychiatr Res (2014) 0.82
Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production. Neurobiol Dis (2008) 0.81
The regulation of AβPP expression by RNA-binding proteins. Ageing Res Rev (2012) 0.81
GFAP expression and social deficits in transgenic mice overexpressing human sAPPα. Glia (2013) 0.81
Increased seizure susceptibility of the hippocampus compared with the neocortex of the immature mouse brain in vitro. Epilepsia (2005) 0.80
Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease. J Biol Chem (2016) 0.79
Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol Psychiatry (2016) 0.79
Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Sci Rep (2016) 0.79
Developing BACE-1 inhibitors for FXS. Front Cell Neurosci (2013) 0.78